Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
111, Inc. to Participate in Fireside Chat with Water Tower Research on September 5, 2024 2024-08-27 20:00
JW Therapeutics Announces NMPA Approval of the Supplemental Biological License Application for Carteyva® in Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma 2024-08-27 17:00
ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment 2024-08-27 09:00
Fujitsu tackles 'drug loss' in Japan through ecosystem to accelerate digitalization of clinical trials 2024-08-27 08:07
Telix Announces Reorganisation to Deliver on Strategic Priorities 2024-08-27 07:15
Mabwell Announces CDE Approval to Initiate Phase III Clinical Trial of 9MW2821 for Urothelial Carcinoma in Combination with PD-1 Inhibitor 2024-08-26 22:00
Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration 2024-08-26 21:00
Actinogen announces further positive results on depression in the XanCIDD phase 2a trial 2024-08-26 20:30
I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference 2024-08-26 19:00
CStone Reports 2024 Interim Results and Recent Corporate Updates 2024-08-23 22:20
Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC to Initiate Phase III Clinical Trial for the Treatment of Cervical Cancer 2024-08-23 22:00
CanariaBio Inc Announces Enrollment Completion of randomized Phase 2 study of Oregovomab in combination with chemotherapy as neo-adjuvant treatment of patients with Advanced Ovarian Cancer 2024-08-23 20:00
GenFleet Announces the First Approval of a KRAS G12C Inhibitor in China for Treatment of Advanced Non-small Cell Lung Cancer Patients Harboring KRAS G12C Mutation 2024-08-23 19:30
Corina Intrauterine Drug-Eluting System approved in China as a novel treatment for patients with moderate-to-severe intrauterine adhesions (IUA) 2024-08-23 18:45
Antengene Announces 2024 Interim Financial Results, Highlights Progress in R&D and Commercialization 2024-08-23 12:32
Ascentage Pharma Announces 2024 Interim Results 2024-08-22 23:36
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program 2024-08-22 21:30
Clarity receives FDA Fast Track Designation for 64Cu-SAR-bisPSMA 2024-08-22 21:04
Stem Cell Therapy developers I Peace and iCamuno Biotherapeutics Start Natural Killer Cell Trial for Ovarian Cancer 2024-08-22 21:00
Ractigen Therapeutics Announces U.S. FDA Orphan Drug Designation (ODD) granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy 2024-08-22 20:00
1 17 18 19 20 21 412